1. Market Research
  2. > Drug Discovery And Development Industry

Drug Development Industry, December 2016 Market Reports from Top Publishers

You might be interested in: Cloud Computing, Therapy, Infectious Disease, Blood Disease, Dermatological Condition, Autoimmune Disease, Digestive System Disorder, Neurological Disorder, Pharmaceutical, Respiratory Disease, Cardiovascular Disease, Eye Disease, Genitourinary System Disease, Anti-Infective, Musculoskeletal Disorder, Lymphoma, Leukemia, In Vitro Diagnostic Reagent, Breast Cancer, Injectable Delivery.


 
1-10 of 21 reports for Drug Development

Purchase Reports From Reputable Market Research Publishers

Global Biosimulation Market Growth, Trends & Forecasts (2016 - 2021)

Global Biosimulation Market Growth, Trends & Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The global market for biosimulation is expected to reach USD 1.88 billion by the end of 2020, growing at a CAGR of around 17.3% from 2014 to 2020. The simulating of biological process with the help of ...

Diabetes & Obesity Drug Development Pipeline Review, 2016

Diabetes & Obesity Drug Development Pipeline Review, 2016

  • $ 3995
  • Company report
  • December 2016
  • by GBI Research

Diabetes & Obesity Drug Development Pipeline Review, 2016 Summary The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type ...

Ophthalmology Drug Development Pipeline Review, 2016

Ophthalmology Drug Development Pipeline Review, 2016

  • $ 3995
  • Company report
  • December 2016
  • by GBI Research

Ophthalmology Drug Development Pipeline Review, 2016 Summary Ophthalmology disorders are associated with the eyes and visual system. If left untreated, serious long-term co-morbidities such as diabetes, ...

Translational Drug Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Translational Drug Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary Translational Drug Development LLC (TD2) is a drug development organization that specializes in providing oncology treatments to cancer patients. The organization provides services such as regulatory ...

International Drug Development Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Drug Development Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary International Drug Development Institute (IDDI) provides clinical data collection, analysis, trial design and trial reporting. It offers services such as biostatistical services and eClinical services, ...

Global Alliance for TB Drug Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Global Alliance for TB Drug Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary Global Alliance for TB Drug Development (TB Alliance) is a non-profit organization that discovers and develops drugs to treat tuberculosis. The organization offers products such as natural products, ...

Early Stage Drug Development in Oncology: Analytical Tool

Early Stage Drug Development in Oncology: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Deals & Alliances in Oncology Drug Development: Analytical Tool

Deals & Alliances in Oncology Drug Development: Analytical Tool

  • $ 14914
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Vital Signs - Lowering Drug Development Costs with Genetically Modified Swine 

Vital Signs - Lowering Drug Development Costs with Genetically Modified Swine 

  • $ 450
  • Industry report
  • March 2016
  • by Frost & Sullivan

Lowering Drug Development Costs with Genetically Modified Swine The US pharmaceutical industry spends approximately $ billion annually to develop new pharmaceutical drugs and medical devices. Today, a ...

Lateral Flow Assay Market by Product Application, Veterinary, Drug Development Technique End User - Global Forecast to 2020

Lateral Flow Assay Market by Product Application, Veterinary, Drug Development Technique End User - Global Forecast to 2020

  • $ 5650
  • Industry report
  • March 2016
  • by MarketsandMarkets

The global lateral flow assay market is expected to grow at a strong CAGR of 8.3% during the forecast period of 2015 to 2020 and is estimated to reach USD 6.78 billion by 2020. The growth in this market ...

About 18000 reports for Drug Development

Download Unlimited Documents from Trusted Public Sources

Covance Inc. - Annual Report, February 2015

  • February 2015
    128 pages
  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.